What are you looking for?
Start main content



The recent emergence of a novel coronavirus disease (COVID-19) has sparked global concern with its increasing number of cases and widening geographical spread of the disease. The article “The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China” indicated that COVID-19 infection in Wuhan appeared clinically milder than SARS or MERS in terms of severity, case fatality rate and transmissibility, which in turn increased the risk of cases remaining undetected. It urged a more concerted and collaborative global effort to reduce the threat of zoonotic diseases by sharing experience and learning from all geographical regions( Int J Infect Dis. 2020 Feb;91:264-266. doi: 10.1016/j.ijid.2020.01.009. Epub 2020 Jan 14.)


Anyone interested in future collaboration in this field of research is welcome to contact our key investigator Prof David Hui in the Department of Medicine and Therapeutics, CUHK. Prof Hui is the director of Stanley Ho Centre for Emerging Infectious Diseases. His research focuses on respiratory failure and sleep disordered breathing, management of emerging severe acute respiratory infections, safety of respiratory therapy and prevention of nosocomial infections in the post SARS era, common airway diseases.


Read full article:


More about CU Medicine on COVID-19:

More about research at CU Medicine: